Article
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms.
Blood advances - 8 Apr 2025
Stewart Brittany L, Carraway Hetty E, Alvarez Adriana L, Lesmana Harry, Molina John, Tu Zheng Jin, Bosler David S, Gerds Aaron, Jha Babal, Calvaresi Emilia, Nakitandwe Joy, Singh Abhay
Abstract excerpt
ABSTRACT: The Janus kinase 2 (JAK2) V617F mutation activates the transcription pathway and has been well characterized as a driver of myeloproliferative neoplasms (MPNs). Recently, there has been a heightened interest in understanding germ line predisposition to hematologic malignancies such as MPN, including several reports of familial MPN. Here, we retrospectively analyzed medical records and data from genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
